SEC Form 4 · accession 0001384101-19-000028
VERACYTE, INC. · VCYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Kennedy
Officer — Chief Financial Officer
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 7:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001384101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2019 | A | 8,000 | $0.00 | A | 40,603 | D | |
| Common StockF3 | Feb 28, 2019 | A | 32,000 | $0.00 | A | 72,603 | D | |
| Common StockF4,F5 | Mar 2, 2019 | F | 1,053 | $0.00 | D | 71,550 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $20.21 | Feb 28, 2019 | A | 60,000 | A | — | Feb 27, 2029 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Restricted stock units awarded on February 28, 2019 vest 25% on March 2, 2020 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- F2Includes 2,244 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on July 31, 2018 and 2,245 shares acquired under the ESPP on January 1, 2019.
- F3Restricted stock units awarded on February 28, 2019 vest 25% on February 28, 2021 and 75% on February 28, 2022 subject to continuing employment of the Reporting Person on each vesting date.
- F4The reporting person is reporting the withholding of 1,053 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,575 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4.
- F5Includes 2,244 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2018 and 2,245 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2019.
- F6The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.